Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Schematic of signaling pathways targeted by MLN0128 and TSA. AKT is ...
MLN0128 ; CAS No:1224844-38-5
MLN0128 inhibits mTORC1 and mTORC2 signaling. (A) MDA-MB-231, ACHN ...
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic ...
MLN0128 is mainly cytostatic in human B-ALL cells. (A) Cell lines ...
MLN0128 inhibits bleomycin-induced lung fibrosis. Mice were treated ...
MLN0128 inhibits bleomycin-induced fibrosis. In (A) mice were treated ...
MLN0128 inhibits mTOR pathway activity and colony formation in MCC ...
MLN0128 has potent antitumor efficacy in vitro . (A) Sixteen cell lines ...
Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant ...
Effect of MLN0128 on c-Myc expression and Akt/mTOR pathway in MCC ...
Biochemical analysis of PD901 (50 μM) and/or MLN0128 (50 nM) treatment ...
(PDF) Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC ...
MLN0128 is effective in cell lines with acquired rapamycin resistance ...
MLN0128 and TSA inhibit the proliferation of breast cancer cells more ...
Dual mTOR Kinases MLN0128 Inhibitor Sensitizes HR+/HER2+ Breast Cancer ...
Effects of PD901 and/or MLN0128 on AKT/YapS127A CCA tumor cell ...
MLN0128 induces G0/G1 cell cycle arrest and cell death in MCC cells. A ...
(PDF) Dual mTOR Kinases MLN0128 Inhibitor Sensitizes HR+/HER2+ Breast ...
Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC ...
MLN0128 inhibits the function of AML-derived xenograft leukemic cells ...
MLN0128 inhibits HB cell growth via targeting the mTOR pathway. A. IC ...
Anti-leukemic effect of MLN0128 in AML. AML cell lines A, B. and AML ...
Combined cabozantinib and MLN0128 treatment has a potent antineoplastic ...
Therapeutic efficacy of PD901 and MLN0128 in AKT/YapS127A preclinical ...
Combination of palbocilclib and MLN0128 synergistically inhibited ...
Combined targeting with trametinib and MLN0128 in MCC cell lines. (a ...
MLN0128 and AZD1775 is effective in repression of SCLC xenograft ...
PD901 and MLN0128 inhibit HCC cell growth in vitro. (A,B) IC 50 values ...
Effect of PD901 (50 μM) and/or MLN0128 (50 nM) on cell cycle ...
Inhibitory mechanisms of MLN0128 on AML cell lines (A) and on a ...
Efficacy of the investigational mTOR kinase inhibitor MLN0128 / INK128 ...
Biochemical analysis of PD901 and/or MLN0128 on AKT/YapS127A CCA tumor ...
CyTOF identifies Inhibitory effect of MLN0128 on AML stem/progenitor ...
The cytotoxic effect of TOR-KI compound MLN0128 inhibition is fully ...
MLN0128 and AZD1775 inhibit SCLC cell proliferation in vitro. A ...
MLN0128 has in vivo antitumor efficacy. Mice bearing ZR75-1, MCF7 ...
Strikingly, combined Palbociclib and MLN0128 treatment resulted in ...
A phase II study of the dual mTOR inhibitor MLN0128 in patients with ...
Pan-mTOR抑制剂MLN0128对AKT和Yap共表达诱导的小鼠肝内胆管癌有效,Journal of Hepatology - X-MOL
Sapanisertib (MLN0128, INK-128) | mTOR Inhibitor | CAS 1224844-38-5 ...
Design, Synthesis, and Biological Evaluation of mTOR-Targeting PROTACs ...
Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in ...
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma ...
RPPA identifies MLN0128-triggered compensatory signaling pathways. A ...
Effect of PD901/MLN0128 combination on the lesions of AKT/c-MET mice ...
Sapanisertib (MLN0128) | 购买mTOR 抑制剂 - Selleck
Effects of alpelisib/MLN0128 treatment on the levels of putative target ...
Sapanisertib (MLN0128)说明书_用法用量_副作用-海南特药-盛诺一家
(PDF) MLN0128, a novel mTOR kinase inhibitor, disrupts survival ...
Combined alpelisib/MLN0128 induces tumor regression in HCC lesions from ...
INK 128 (MLN0128) - Potent mTORC1/2 Inhibitor | APExBIO
Synergistic anti-cancer activity of CDK4/6 inhibitor palbociclib and ...
Figure 1 from Equivalent Benefit of Rapamycin and a Potent mTOR ATP ...
Effects of combined cabozantinib/MLN0128 treatment on HCC cell ...
Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal ...
Heightening energetic stress selectively targets LKB1-deficient non ...
Simultaneously targeting DNA damage repair pathway and mTORC1/2 results ...
RapaLink-1, a Third-Generation Bivalent mTOR Inhibitor, Combines ...
1224844-38-5[INK 128 (MLN0128) 98%]- Jizhi Biochemical
Sapanisertib (MLN0128) supplier | CAS 1224844-38-5 | AOBIOUS
美国APExBIO中文官网 - INK 128 (MLN0128)|MTOR(TORC-1/-2) inhibitor,potent and ...
Effects of PD901/MLN0128 combination on hepatocarcinogenesis in ...
aladdin 阿拉丁 I128086 INK 128 (MLN0128),mTOR抑制剂 1224844-38-5 ≥98% ...
Sapanisertib (MLN0128),Sapanisertib (MLN0128),1224844-38-5,上海阿拉丁生化科技股份 ...
MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and ...
